205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
9.20%
Net income growth above 1.5x AVGO's 3.47%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
3.00%
D&A growth well above AVGO's 0.21%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
-112.90%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
-28.36%
Negative yoy SBC while AVGO is 16.18%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
24.31%
Slight usage while AVGO is negative at -263.27%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
266.67%
AR growth while AVGO is negative at -131.09%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
-25.00%
Both reduce yoy inventory, with AVGO at -242.50%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
211.54%
Lower AP growth vs. AVGO's 713.33%, indicating prompt payments. David Dodd would confirm no lost opportunity in interest-free credit if expansions are underfunded.
-40.30%
Both reduce yoy usage, with AVGO at -73.94%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
141.82%
Well above AVGO's 189.47%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
10.91%
Some CFO growth while AVGO is negative at -9.30%. John Neff would note a short-term liquidity lead over the competitor.
47.54%
CapEx growth well above AVGO's 10.40%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
-47.54%
Negative yoy acquisition while AVGO stands at 99.96%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
-312.55%
Negative yoy purchasing while AVGO stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
10.00%
We have some liquidation growth while AVGO is negative at -33.33%. John Neff notes a short-term liquidity advantage if competitor is holding or restricted.
32.42%
We have some outflow growth while AVGO is negative at -99.46%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
-254.26%
We reduce yoy invests while AVGO stands at 66.98%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
No Data
No Data available this quarter, please select a different quarter.
32.88%
We slightly raise equity while AVGO is negative at -90.91%. John Neff sees competitor possibly preserving share count or buying back shares.
47.16%
Repurchase growth above 1.5x AVGO's 26.54%. David Dodd would see a strong per-share advantage if the share price is reasonably valued.